NCT00791427View on ClinicalTrials.gov

ERG/EOG Study in AMD Patients Treated With Ranibizumab

CompletedOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Age-Related Macular Degeneration

Interventions

DRUG

Ranibizumab

0.05 ml of ranibizumab injected into the eye monthly for one year

Trial Locations (1)

55404

The Retina Center, Minneapolis

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Retina Center, Minnesota

OTHER